|
COPYRIGHT 2008 International Medical News Group
Discovery for 66 suits alleging that gadolinium-based contrast led to nephrogenic systemic fibrosis (NSF) has been consolidated in a federal court in Ohio. The plaintiffs allege that the gadolinium-based contrast agent used during magnetic resonance imaging led to NSE NSF has occurred only in patients with preexisting renal compromise....
Read the full article for free courtesy of your local library.
|